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Background: Hedgehog acyltransferase 
(HHAT) palmitoylates hedgehog proteins and is 
a potential target in cancer. 
Results: HHAT has 10 transmembrane domains, 
2 reentrant loops and 4 palmitoylation sites. 
Conclusion: HHAT topology is determined and 
protein is multi-palmitoylated, which modulates 
protein function. 
Significance: Elucidating HHAT topology and 
post-translational modifications is crucial to 
understanding its acyltransferase activity and in 
developing new strategies to treat cancer. 
 
ABSTRACT 
Hedgehog proteins are secreted morphogens 
that play critical roles in development and 
disease.  During maturation of the proteins 
through the secretory pathway they are 
modified by the addition of N-terminal 
palmitic acid and C-terminal cholesterol 
moieties, both of which are critical for their 
correct function and localisation.  Hedgehog 
acyltransferase (HHAT) is the enzyme in the 
endoplasmatic reticulum (ER) that 
palmitoylates Hedgehog proteins, is a 
member of a small subfamily of MBOAT 
proteins that acylate secreted proteins, and is 
an important drug target in cancer.  However 
little is known about HHATs structure and 
mode of function.  We show that HHAT is 
comprised of 10 transmembrane domains and 
2 reentrant loops with the critical His and 
Asp residues on opposite sides of the ER 
membrane.  We further show that HHAT is 
palmitoylated on multiple cytosolic cysteines, 
which maintain protein structure within the 
membrane.  Finally, we provide evidence that 
mutation of the conserved His residue in the 
hypothesised catalytic domain results in a 
complete loss of HHAT palmitoylation, 
providing novel insight into how the protein 
may function in vivo.   
 
INTRODUCTION 
The Hedgehog (Hh) family of proteins are 
secreted morphogens which play a significant 
role during embryonic development in 
determining organogenesis and anterior-
posterior patterning of various tissues, including 
the central nervous system and limb and digit 
formation (1,2).  Aberrant activation of Hh 
signaling in various cancers result in promotion 
of cancer growth and metastasis (3,4) and small 
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molecule inihbitors for this pathway are in use in 
various clinical trials. 
A unique feature of the Hh proteins are that 
during maturation through the secretory 
pathway, they are post-translationally modified 
by the addition of a cholesterol moiety to its C-
terminus, via an ester linkage, while a palmitate 
(C16:0) fatty acid is also added on the conserved 
N-terminal cysteine residue via an amide linkage 
(5).  Palmitoylation of Hh proteins is catalysed 
by the protein acyltransferase (PAT) Hedgehog 
acyltransferase (HHAT) (6). 
These modifications produce the mature and 
functional Hh signaling molecule and are crucial 
for the correct function of the protein.  They not 
only direct the formation of large Hh multimers 
upon secretion from the producing cells, but they 
also determine the proper release and targeting 
of the proteins, as well as having a significant 
effect on the potency of the protein to activate 
the signaling pathway on the receiving cells (7-
9).  For these reasons, disrupting the post-
translational modification of Hh proteins, and 
hence inhibiting the formation of functional 
signaling molecules, is an attractive new method 
of inhibiting the Hh pathway in cancer. 
HHAT is a multipass transmembrane (TM) 
domain protein located in the endoplasmic 
reticulum (ER) of cells (6,10), and a member of 
a small sub-group of the membrane-bound O-
acyltransferase (MBOAT) superfamily of 
proteins, that specifically acylates secreted 
proteins.. Other members of this important sub-
group include Porcupine (PORCN) which 
palmitoyleoylates (C16:1) the Wnt family of 
proteins and ghrelin-O-acyltransferase (GOAT) 
which octanoylates (C8:0) the appetite-sensing 
peptide ghrelin (11).  All MBOAT proteins are 
characterized by their MBOAT homology 
domain, a region of highly conserved residues 
including an invariant His residue (His379 in the 
case of HHAT) and a highly conserved Asn - or 
in the case of HHAT, Asp (Asp339) - residue 
30-45 amino acids upstream (11,12).  These 
amino acids are proposed to be catalytic, 
although this is still not clear, especially for 
HHAT where mutation of the His to an Ala still 
retains significant PAT activity (13). Recent 
studies by our group and others provided proof 
of principle that inhibiting HHAT function is a 
valid method of inhibiting Hh signaling in 
cancer (14-16). 
Despite the importance of HHAT in Hh 
signaling and its therapeutic potential in cancer, 
little is understood about the structure of the 
protein and the identity of the catalytically 
important amino acids, information that may 
guide future studies in development of small 
molecule inhibitors of HHAT as well as into 
other functions HHAT may have in the cell. In 
this study, we determine HHAT topology using 
a variety of experimental methods.  Our data 
suggest that HHAT contains 10 TM domains 
and 2 re-entrant loops (RLs) and that the 
invariant His379 is luminal, while Asp339 is on 
the cytosolic side of the ER.  Furthermore, we 
show that HHAT is itself palmitoylated at 
multiple cytoplasmic Cys residues, and His379 
is critical for the palmitoylation of HHAT, while 




Cell culture and transfection - HEK293a and 
HeLa cells were cultured in high glucose 
(4.5g/L) DMEM supplemented with Glutamax 
(Life Technologies, Paisley, UK) containing 
10% foetal bovine serum (FBS, Sigma, 
Gillingham, UK).  All cells were grown at 37 °C 
in a humidified incubator under 5% CO2.  Cells 
were transfected at 70% confluence using 
Turbofect (Thermo Fisher Scientific, 
Cramlington, UK) according to the 
manufacturer’s specifications. 
Plasmid construction and mutagenesis - Full-
length human HHAT cDNA (Accession No: 
BC117130) expression vector with C-terminal 
V5 and 6xHis epitopes has previously been 
described (15).  The cloned cDNA sequence 
carries a missense mutation compared to the 
human HHAT consensus sequence, a serine to 
aspartate change in position 182 of the protein.  
Prior to proceeding with making mutants for 
HHAT for topology analysis, the missense 
mutation was corrected to serine by 
QuickChange II site-directed mutagenesis 
(forward primer: 
CTACTACACCAGCTTCAGCCTGGAGCTCT
GCTGGCAGCAGC; reverse primer: 
CAGGCTGAAGCTGGTGTAGTAGAGGCAG
CGAACGGTCAGCG).  All subsequent HHAT 
mutants and truncates for topological analysis 
were made using the corrected vector expressing 
HHAT-V5-Hisx6 as template. 
For cysteine mapping topology analysis, selected 
cysteines were mutated to alanine by Q5 site-
directed mutagenesis (NEB, Hitchin, UK).  Q5 
mutagenesis was also used for the introduction 
of the TEV protease site, ENLYFQG, in the 
HHAT-TEV mutants. 
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For the production of the V5 topology clones, 
the V5-6xHis epitope from the HHAT-V5-6xHis 
construct was removed and replaced with a 
FLAG epitope (DYKDDDDK) by Q5 
mutagenesis, followed by insertion of the V5 
epitope (GKPIPNPLLGLDST) at the required 
sites. 
For N-glycosylation analysis, an N-glycosylation 
site (Asp-Leu-Thr) was introduced by 
QuickChange II site-directed mutagenesis into 
the spacer region between the gene of interest 
cloning site and the V5-Hisx6 epitope of the 
empty destination vector pcDNA-DEST40 used 
for HHAT cloning Next, full length HHAT or 
HHAT truncations HHAT-157-493 and 
HHAT-192-493 were amplified from the 
HHAT expression vector described above (15) 
and cloned into the modified destination vector 
using Gateway cloning resulting in expression 
vectors carrying N-glycosylation, V5 and Hisx6 
epitopes at the C-terminus.  All clones were 
verified by sequencing. 
SDS-PAGE and immunoblotting - Separation of 
proteins was performed by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE), using 10 or 15% Tris gels and 
Tris-glycine-SDS running buffer.  Samples were 
prepared in NuPAGE® LDS 4 x sample loading 
buffer (Life Technologies) and 10% (v/v) 2-
mercaptoethanol (unless stated otherwise).  The 
protein ladder used for comparison of molecular 
weight was Precision Plus Protein® Standards 
All Blue (Bio-Rad, Herts, UK).  Gels were run 
using the Mini-PROTEAN® Tetra Cell System 
and power supply unit (Bio-Rad).  
Fluorescently-tagged proteins were imaged (540 
nm excitation and 595 nm emission, channel 
Cy3) using an Ettan DIGE Imager (GE 
Healthcare, Bucks, UK) and images were 
analysed with ImageQuantTM TL software (GE 
Healthcare). 
Proteins were transferred from SDS-PAGE gels 
to a PVDF membrane (Millipore, UK) using a 
semi-dry transfer unit (Hoefer, Holliston, MA, 
USA).  Membranes were blocked with blocking 
solution (5% w/v milk powder (Marvel), 
dissolved in PBS) for 1 h at room temperature 
and washed with PBS-T (phosphate buffered 
saline, PBS, containing 0.05% Tween-20 
(Sigma)) and probed with appropriate 
antibodies.  Antibodies and their sources were as 
follows: mouse anti-V5 monoclonal antibody 
(1:10,000 dilution, Life Technologies); mouse 
anti-6xHis antibody (1:1000, AD1.1.10, R&D 
Systems, Abingdon, UK), rabbit anti-6xHis 
antibody (1:1000, ab137839, Abcam, 
Cambridge, UK); goat anti-Grp94 antibody 
(1:200 dilution, C-19, Santa Cruz 
Biotechnology, UK); anti-calnexin-N-terminus 
mouse monoclonal IgG1 (1:1000, AF18, Sigma).  
Secondary antibodies used were: goat anti-
mouse IgG2a-HRP (1:20,000 dilution, Southern 
Biotech, UK); goat anti-mouse IgG1-HRP 
(1:20.000, Southern Biotech); goat anti-rabbit-
HRP IgG (1:20,000, Southern Biotech); or after 
immunoprecipitations, mouse anti-rabbit IgG-
HRP VeriBlot (1:1000, Abcam, UK). 
Visualisation was carried out by enhanced 
chemiluminescence kit (Pierce ECL2 Western 
Blotting Substrate, Thermo Scientific, UK) 
according to manufacturer’s instructions and on 
an Ettan DIGE Imager (GE Healthcare, UK), 
excitation at 480 nm, emission at 530 nm 
(channel Cy2).  Images were analysed with 
ImageQuantTM TL software. 
TEV cleavage of ER microsomes - HEK293a 
cells were transfected with wild-type or TEV 
mutant HHAT-V5-6xHis constructs.  After 48 h, 
cells were washed twice with cold HCN buffer 
(50 mM Hepes, pH 7.5, 150 mM NaCl, 2 mM 
CaCl2) and pelleted at 800 × g for 2 min.  Cells 
were passed through a 23g needle 10 times and 
then intact cells and nuclei were pelleted at 800 
x g for 5 min at 4
o
C.  The supernatant was then 
ultracentrifuged at 100,000 x g for 1 h to obtain 
microsomes, which were resuspended in 
ProTEV protease buffer (50mM HEPES pH 7.0, 
0.5mM EDTA, 1mM DTT) and protein 
concentration determined using the DC protein 
assay (BioRad).  Due to lower expression levels 
of some mutants, an initial Western Blot was 
performed on 5g of each microsome 
preparation in order to determine the amount of 
HHAT expression.  The final concentration of 
microsome preparation treated with ProTEV was 
then normalised for HHAT expression.  To 
every 20g of microsome suspension 1l (5U) 
of ProTEV Plus protease (Promega, 
Southampton, UK) was added and then 
preparations were incubated at 25°C for 4 h.  
Reaction was stopped with NuPAGE® LDS 1 x 
sample loading buffer (Life Technologies).  
Proteins were then separated by SDS-PAGE and 
analysed by immunoblotting with anti-V5 
monoclonal antibody (1:10,000 dilution, Life 
Technologies).  After probing for V5, blots were 
re-probed with anti-6xHis (1:1000, AD1.1.10, 
R&D Systems) antibody. 
Metabolic labelling with alkynyl-palmitate 
(YnPalm) and Copper-catalyzed [3+2] 
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cycloaddition (CuAAC) reaction - HEK293a 
cells were transfected with wild-type or 
cysteine-mutant HHAT-V5-6xHis constructs.  
36 h post-transfection, medium was exchanged 
for feeding medium (DMEM, 3% FBS plus 50 
M alkynyl-palmitate analogue pentadec-14-
ynoic acid (YnPalm) in DMSO(17), or the same 
volume of DMSO used as vehicle control .  
After 16 h, cells were rinsed twice with ice-cold 
PBS and then lysed with 100l lysis buffer 
(0.1% SDS, 1% Triton X-100, EDTA-free 
Complete protease inhibitor (Roche Diagnostics, 
Burgess Hill, UK) dissolved in PBS).  Lysates 
were centrifuged at 16,000 x g for 10 min to 
remove insoluble material.  The supernatant was 
collected and used for further experiments.   
Cell lysates (20 μg of total proteins) were 
reacted with CuAAC reaction cocktail 
containing azido-TAMRA-PEG-Biotin (AzTB) 
(10 mM stock in DMSO) at 100 μM final 
concentration(17), CuSO4 (50 mM stock in 
water) at final concentration of 1 mM, TCEP (50 
mM stock in water) at final concentration of 1 
mM and TBTA (10 mM stock in DMSO) at final 
concentration of 100 μM.  The reaction was 
vortexed for 1 h at room temperature and EDTA 
(100 mM in water stock) was added to final 
concentration of 10 mM.  Proteins were 
precipitated by addition of 4 vols of methanol, 1 
vol of chloroform and 3 vols of water.  The 
sample was centrifuged for 5 min at 16,000 x g 
and the pellet was washed twice with room 
temperature (RT) methanol.  The protein 
precipitates were resuspended in 2% SDS in 
PBS and further diluted to 1 mg/mL of total 
protein concentration and final SDS 
concentration of 0.2% with PBS.  An aliquot of 
this sample was taken for SDS-PAGE analysis. 
200 μg of proteins from cell lysate were 
immunoprecipitated with 1 µg anti-V5 antibody.  
Following overnight incubation at 4°C on a 
rotating wheel, 25 μL of Pureproteome protein-
G magnetic beads (Merck Millipore, Watford, 
UK) were added to each sample and incubated 
for 1 h at 4 °C on a rotating wheel.  The beads 
were washed (5 x) with lysis buffer and 
resuspended in 20 μL of PBS and freshly 
premixed CuAAC reaction reagents at 
appropriate concentrations (as described above) 
were added.  After 1 h of vortex-mixing, the 
beads were washed (5 x) with lysis buffer and 
mixed with NuPAGE® LDS 1 x sample loading 
buffer (Life Technologies) and 10% (v/v) 2-
mercaptoethanol and incubated with vortexing at 
room temperature for 1 h.  Proteins were 
separated by SDS-PAGE, in-gel fluorescence 
was used to visualise YnPalm-modified proteins, 
which were then transferred to PVDF 
membranes and analysed by immunoblotting 
with anti-6xHis (1:1000, ab137839, Abcam) 
antibody followed by mouse anti-rabbit IgG 
(HRP) VeriBlot (1:1000, Abcam) secondary 
antibody. 
Hydroxylamine (NH2OH) treatment of YnPalm-
modified proteins - After preparation of lysates 
from metabolic labelling of palmitoylated 
proteins with YnPalm (see section above) lysates 
were diluted 1:1 with 2M NH2OH pH 7.5 or 2M 
Tris pH 7.5.  Samples were then incubated for 5 
h at RT while mixing with a rotator wheel.  
HHAT proteins were then immunoprecipitated 
onto protein G magnetic beads with anti-V5 
antibody and treated by CuAAC, as described 
above.  Proteins were separated by SDS-PAGE, 
in-gel fluorescence was used to visualise 
YnPalm-modified proteins, which were then 
transferred to PVDF membranes (Millipore) and 
analysed by immunoblotting with anti-6xHis 
antibody. 
mPEG labelling of cells - HEK293a cells were 
transfected with wild-type or cysteine mutant 
HHAT-V5-6xHis constructs.  After 48 h, cells 
were washed twice with ice-cold HCN buffer, 
and pelleted at 800 × g for 2 min.  Cells were 
then semipermeabilised in 0.02% digitonin or 
fully permeabilised in 1% Triton X-100 on ice 
for 20 min (in HCN buffer supplemented with a 
protease inhibitor cocktail).  In the experiments 
with microsomal fractions, 20g of microsomal 
fractions in cold HCN buffer with or without 
0.2% Triton X-100 were used.  1mM maleimide-
polyethyleneglycol (mPEG) 5 kDa (Laysan Bio 
Inc, AL, USA) was then added to each sample 
with or without 20 mM DTT for 30 min on ice, 
after which all samples were brought to a final 
concentration of 1% TX-100/20 mM DTT and 
incubated an additional 15 min on ice.  Lysates 
were clarified by spinning at 16,000 × g for 10 
min and the proteins in the supernatants were 
separated by SDS-PAGE.  Samples were 
analysed by immunoblotting with anti-V5, anti-
6xHis or anti-Grp94 (1:200 dilution, C-19, Santa 
Cruz Biotechnology, UK) antibodies.   
HHAT V5-topology determination - Topology 
determination by V5 accessibility was 
performed as follows: 1.5 x 10
4
 HeLa cells were 
plated on 96-well imaging plates (ibidi) and 
transfected with wild-type or mutant HHAT-V5-
FLAG constructs.  After 48 h, cells were fixed 
with 3% paraformaldehyde (PFA) in PBS pH 7.5 
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for 10min at room temperature, washed 
thoroughly and then semipermeabilised in 0.02% 
digitonin/PBS or fully permeabilised in 0.2% 
Triton X-100/PBS on ice for 10 min.  HHAT 
was visualised with mouse monoclonal anti-V5 
IgG2A (1:300, Life Technologies) and rabbit 
polyclonal anti-DDDDK (1:300, ab1162, 
Abcam) followed by AlexaFluor488-conjugated 
anti-mouse IgG2A and AlexaFluor555-
conjugated anti-rabbit secondary antibodies 
(Life Technologies), respectively.  As a control 
for the permeabilisation of the cells, 
untransfected cells treated in the same way as 
the HHAT-transfected cells were stained for 
calnexin using two different antibodies, one 
against the N-terminus of the protein, mouse 
monoclonal IgG1 (AF18, 1:50, Santa Cruz), and 
one against the C-terminus, rabbit polyclonal 
(ADI-SPA-860, 1:100, Enzo Life Sciences), 
followed by AlexaFluor488-conjugated anti-
mouse IgG1 and AlexaFluor555-conjugated 
anti-rabbit secondary antibodies, respectively.  
Imaging was performed using a Zeiss Axiovert 
200 widefield microscope with a LD Achroplan 
40x 0.60 KORR Ph2 objective and Hamamatsu 
OrcaER CCD camera in the FILM imaging 
facility.  Colocalisation analysis was performed 
using Volocity image analysis software 
(PerkinElmer, Cambridge, UK).  The two 
channels were thresholded by drawing a region 
of interest (ROI) in a background area of the 
image.  The mean intensity of the region for 
each channel was calculated and this was set as 
the lower threshold.  ROIs were then drawn 
around the ER regions of transfected cells and 
then the Manders colocalisation coefficient was 
determined.  Images from at least 40 cells from 3 
independent experiments were used in the 
analysis. 
In vitro expression of HHAT N-glycosylation 
mutants - In vitro protein expression of full 
length HHAT, HHAT-157-493 and HHAT-
192-493 truncations containing a C-terminal 
N-glycosylation motif was performed using the 
TnT Quick Coupled Transcription/Translation 
System (Promega) based on rabbit reticulocyte 
lysate with canine pancreatic microsomes.  40 µl 
TnT master mix, 1 µg plasmid template, 1 µl 
methionine (1 mM), and 3.6 µl canine pancreatic 
microsomes were mixed on ice.  Volume was 
adjusted to 50 µl with RNase-free water and 
reactions were incubated at 30°C for 1.5 h.   
Removal of protein N-glycosylation by treatment 
with PNGase F - After in vitro protein 
transcription and translation, microsomal 
membranes were purified by diluting the 
components of the TnT reaction to 500 µl in 
PBS and carefully layered on top of 100 µl of 
5% (w/v) sucrose in 1.5 ml tubes for 
ultracentrifugation (Beckman).  The samples 
were centrifuged at 100,000 × g for 45 min at 
4°C to pellet the membranes.  Supernatant was 
discarded, membrane pellet was resuspended in 
10 µl of glycoprotein denaturing buffer supplied 
with the PNGase F kit (NEB) and heated at 
100°C for 10 min.  The samples were incubated 
at 37°C for 1 h with or without PNGase F 
(according to manufacturer’s instructions).  The 
reactions were stopped by addition of 4× 
NuPage LDS sample buffer (Invitrogen) and 
analysed by immunoblotting against the V5 
epitope. 
Shh in vitro click-chemistry based 
palmitoylation assay - Details of our Shh in vitro 
click-chemistry based palmitoylation assay will 
be reported fully elsewhere (T. Lanyon-Hogg, 
A.I. Magee and E.W. Tate, in preparation).  
Briefly, Shh residues 1-11 were synthesised by 
solid phase peptide synthesis attached to a C-
terminal (PEG)-biotin tag.  YnPalm-CoA was 
synthesised from YnPalm and Co-enzyme A 
hydrate from yeast (Sigma) using standard 1,1’-
carbonyl-diimidazole coupling conditions.  
HEK293a cells were transfected with HHAT-
V5-6xHis (positive control), HHAT-H379A-V5-
6xHis, HHAT-D339N-V5-6xHis, or mCherry 
(negative control) and grown to 70 % 
confluency.  Cells were lysed as previously 
described and membrane fractions collected via 
centrifugation at 100,000 x g for 1 h at 4 °C.  
Membrane fractions were solubilised in 
solublisation buffer (1% (w/v) n-Dodecyl β-D-
maltoside, 10 mM HEPES (pH 7.5), 350 mM 
NaCl) for 1 h at 4 °C, and insoluble material 
removed by centrifugation at 100,000 g for 1 h 
at 4 °C.  Solubilised HHAT-H389A and -D339N 
membrane fractions were normalised to HHAT-
WT expression levels via α-6xHis 
immunoblotting, and 3 µg HHAT-WT or 
mCherry membrane fractions were used for in 
vitro palmitoylation.  1 µM YnPalm-CoA and 1 
µM Shh(1-11)-biotin in reaction buffer (100 mM 
MES (pH6.5), 20 mM NaCl, 1 mM DTT, 0.1% 
(w/v) BSA) were incubated with solubilised 
membrane fractions for 30 min at RT in Reacti-
Bind Streptavidin coated clear wells (Fisher).  
Wells were washed with 3 x 200 µl PBS-T + 1% 
BSA, followed by 3 x 200 µl reaction buffer.  
Wells were then subjected to CuAAC click-
chemistry functionalization with 10 µM azido-
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FLAG peptide, 1 mM CuSO4, 1 mM TCEP, 1 
mM TBTA in PBS-T + 0.1% BSA for 1 h at RT, 
then washed with 3 x 200 µl PBS-T + 1% BSA, 
followed by 3 x 200 µl reaction buffer.  Wells 
were probed with α-FLAG-HRP (Sigma) 
(1:20,000) in PBS-T + 0.1% BSA for 1 h at RT, 
then washed with 3 x 200 µl PBS-T + 1% BSA, 
followed by 3 x 200 µl reaction buffer.  Bound 
α-FLAG-HRP (Sigma) was visualised using BD 
OptEIA TMB reagent (Becton Dickinson) 
according to the manufacturer’s protocol, and 
wells read for optical density at 450 nm. 
Samples were prepared in duplicate and the 
experiment was repeated twice.  
 
RESULTS 
Bioinformatic analysis of HHAT topology - 
There are 7 human HHAT isoforms (UniProt 
ref: Q5VTY9); however, the canonical 
polypeptide sequence is isoform 1, which is 493 
amino acids long.  Topology for this isoform has 
been previously predicted using TMHMM 2.0 
(18) to have 8 transmembrane (TM) helices (13).  
This model, however, had a number of 
inconsistencies in comparison to other MBOAT 
protein topologies, most significantly that the 
critical His379 of the conserved MBOAT region 
of HHAT was predicted to be cytosolic, a 
feature that would be unique within this family 
of proteins and seems inconsistent with catalytic 
activity on Hh proteins in the ER lumen.  A 
recent comparison of different topology 
prediction algorithms identified some as being 
superior for predicting structures of membrane 
proteins (19); the highest-scoring topology 
prediction algorithm was TOPCONS (20).  
Furthermore, the study that recently determined 
the topology of GOAT (21) utilised an advanced 
algorithm MEMSAT-SVM (22) which employs 
a computer learning method, as well as 
considering extra features, such as RLs and 
signal peptides. 
We performed topology predictions for HHAT 
sequences from 22 different species, identified 
on the NCBI RefSeq database (Figure S1) (23) 
using both the TOPCONS and MEMSAT-SVM 
prediction algorithms (data for human HHAT 
sequence shown in Figure 1, data for other 
species not shown).  Significantly, both 
prediction algorithms gave very similar results 
and were internally consistent across different 
species, with models predicted to contain either 
11 or 12 TM domains in both algorithms.   
Loop 8 was the longest and another algorithm 
TMpred (24) predicted an intervening TM, 
although with a low score; the other predicted 
TMs were similar to the TOPCONS and 
MEMSAT-SVM predictions (Figure 1).  
TMpred predicts protein topology through 
several weight-matrices based on the statistical 
analysis from a SWISS-PROT TM protein 
database (release 25).  To test this prediction in 
our experiments we made two mutants within 
loop 8 (numbered 8 and 8b) for all experiments. 
In all sequences analysed, no N-terminal 
cleavable signal peptide was predicted either by 
MEMSAT-SVM or SignalP 4.0 (25).  This was 
also confirmed experimentally (see below).  
Finally, in all topologies, the critical His379 
residue is predicted to be on the luminal side of 
the membrane at the border between predicted 
TM9 and loop 10. 
HHAT topology determination by Tobacco Etch 
Virus (TEV) protease protection assay on 
purified ER microsomes - Based on the predicted 
topology of human HHAT, a number of 
constructs were designed containing TEV 
protease recognition sites (ENLYFQG) within 
predicted loops, which also contained a V5-
6xHis epitope tag on the C-terminus of the 
protein; the insertion sites are indicated in Figure 
1.  TEV protease is a highly site-specific 
cysteine protease from Tobacco Etch Virus.  The 
optimum recognition sequence is ENLYFQ|G 
and cleavage occurs between the Gln and Gly 
residues.   
We isolated intact microsomes containing ER 
membranes from cells expressing HHAT-TEV 
constructs and treated these preparations with 
ProTEV protease in vitro (Figure 2).  We first 
confirmed that the ER membrane was intact by 
checking the ability of the thiol-reactive reagent 
mPEG to modify the non-disulphide-bonded 
cysteine in the ER luminal protein GRP94 
(Figure 2A) (26).  Isolated microsomes treated 
with mPEG had only a single GRP94 band at 
100kDa (Figure 2A - upper blot).  However, if 
0.2% Triton X-100 was added during mPEG 
treatment to permeabilise the membrane, a 
second mPEG-modified band appears (Figure 
2A - middle blot) and this band disappears if 
treated at the same time with 20mM DTT, which 
competes with mPEG reacting with the cysteine 
in GRP94 (Figure 2 A - lower blot).  Having 
confirmed that the microsomes are intact, we 
proceeded with protease treatment. 
Protein levels were adjusted to achieve equal 
levels of mutant HHAT expression and the 
amount of ProTEV protease was adjusted for 
protein concentration (see Experimental 
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Procedures).  In the absence of ProTEV protease 
(Figure 2B-I and 2C-I) all HHAT constructs 
migrated as single ~50kDa bands; however, with 
the addition of ProTEV additional bands 
appeared, indicating successful cleavage of some 
of the HHAT-TEV constructs.  This is 
particularly apparent from the sizes of these 
additional bands, which correspond to the 
expected size of tagged C-terminal peptides 
produced on cleavage of the proteins.  Thus, 
proteins with TEV sites in loops close to the N-
terminus of the protein produce larger cleavage 
products than proteins with TEV sites close to 
the C-terminus of the protein.  Using this 
approach we were able to verify that loops 4, 6, 
8 and 10 were cytosolic (Figure 2B-II, 2C-II).  
Cleavage products indicated with black 
arrowheads), while the C-terminus of the protein 
was also cytosolic, as a HHAT-TEV construct in 
which the TEV recognition sequence was placed 
between the C-terminal V5 and 6xHis epitopes 
showed a loss of 6xHis immunoreactivity 
(Figure 2D).  Mutants HHAT-3 TEV and 
HHAT-8b TEV showed the appearance of a 
band in the presence of TEV, but because of 
background bands obscuring the clear 
appearance of the cleaved product we are unable 
to determine the loop topology reliably (Figure 
2B-II, 2C-II, potential cleavage products 
indicated with grey arrowheads).  Loops 5, 7, 9 
and 11 showed no evidence of TEV cleavage 
and therefore appear to be luminal.  With regard 
to the first two loops of the protein, because of 
the size of the cleavage products coinciding with 
the size of ProTEV and the relatively lower 
immunoreactivity of the cleavage products using 
the anti-V5 antibody (Compare Figure 2B-II and 
2C-II) it was not clear if the protein was cleaved. 
All mutants cleaved when cells were fully 
permeabilised with dodecyl maltoside, showing 
that the cleavage sites were functional (data not 
shown). These experiments are consistent with a 
10 TM model for HHAT topology with 2 RLs 
(RL3 and RL6) and a cytosolic C-terminus 
(Figure 2C-II, diagram beneath blot).   
HHAT mapping by epitope immunoreactivity in 
selectively permeabilised cells - We wanted to 
complement the results obtained with TEV 
protease mapping with an alternative method, 
ideally in a cellular context and in such a manner 
that would give a definite result for loops near 
the termini of HHAT, as well as for the N- and 
C-termini themselves.  We decided to pursue an 
epitope mapping strategy in selectively 
permeabilised cells using indirect 
immunofluorescence.  We generated HHAT 
constructs that were C-terminally tagged with a 
FLAG tag (DYDDDDK) and had a V5 epitope 
(GKPIPNPLLGLDST) inserted at the same 
points at which the TEV protease site had been 
inserted, as well as an N-terminal V5-tagged 
version (see Figure 1).  HeLa cells expressing 
these constructs were fixed and treated with 
0.2% Triton X-100 to fully permeabilise the cell 
membranes, or treated with 0.04% digitonin, 
which selectively permeabilises the plasma 
membrane of the cells but leaves the ER 
membrane intact (21,26).  Cells were then 
stained for both FLAG and V5 epitopes by 
indirect immunofluorescence (Figure 3).  As a 
control for the permeabilisation protocol, cells 
were stained with two different Calnexin 
antibodies, one which recognises the N-terminus 
of the protein and another which recognises the 
C-terminus of the protein.  Calnexin is a type I 
transmembrane domain protein which is 
abundant in the ER and functions as a chaperone 
for secretory glycoproteins (27), the N-terminus 
of which is luminal and the C-terminus 
cytoplasmic (28); thus in digitonin-treated cells, 
the N-terminus specific antibody should not 
react with the protein, but the C-terminus 
specific antibody should react regardless of 
treatment (Figure 3-I).  Similar analysis was 
performed using the HHAT-V5-FLAG 
constructs in permeabilised and semi-
permeabilised cells (data for two mutants shown 
in Figure 3-II and -III).  Images were collated 
from at least three separate experiments and 
Manders’ correlation coefficient was calculated 
for each mutant in the digitonin-treated 
condition to determine if the two probes were on 
the same side of the ER membrane (Figure 3-
IV).  
As expected from the TEV experiments, the C-
terminus of HHAT was cytosolic for all HHAT 
constructs; this also confirmed that none of the 
insertions caused the TMs to flip (Figure 3 and 
data not show).  The N-terminus was also 
cytosolic, as predicted by both TOPCONS and 
MEMSAT-SVM (Figure 3-II).  The staining also 
confirmed that the protein does not contain an 
N-terminal cleavable signal peptide, as the V5 
tag would have been removed in that case.  The 
results for the other mutants correspond mostly, 
but not completely, to the TEV protease 
experiments.  Specifically, loops 2, 3, 5, 6, 8 and 
10 all appeared to be cytosolic, while loops 1, 4, 
7, 9 and 11 were luminal (see schematic in 
Figure 5).  In the case of the loop 9 mutant we 
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decided to make a second mutant in which the 
V5 epitope was shifted C-terminally by three 
amino acids (HHAT-9b V5-FLAG), in order to 
correct for any potential masking of the epitope 
from being in close proximity to a predicted TM 
domain; however, results still suggested the loop 
was luminal.  The results of the epitope mapping 
showed very good overlap with the TEV 
experimental model.  Noteworthy exceptions 
were loops 4 and 5, which the TEV experiments 
place as cytosolic and luminal, respectively, 
while in the epitope mapping the opposite 
orientation is seen.  
To resolve this discrepancy, C-terminal 
truncation mutants of HHAT containing the first 
four or five predicted TMs of HHAT and a C-
terminal N-glycosylation motif followed by the 
V5-6xHis epitope were constructed and 
expressed by in vitro translation in the presence 
of microsomes.  Lysates were then analysed by 
Western blotting to see if the C-terminus of the 
protein was glycosylated or not (Figure 4. This 
method supported a luminal location for loop 4, 
and a cytosolic location for loop 5 thus 
confirming the V5 epitope mapping result 
(Figure 3-IV).  We also confirmed in the same 
way that the C-terminus of full length HHAT is 
cytosolic (Figure 4).  
Based on the TEV protease mapping, the epitope 
mapping on selectively permeabilised cells and 
the glycosylation of HHAT truncations, a 
consensus topology model can be drawn up in 
which HHAT has 10 TM domains and 2 RLs 
(RL3 and RL6; Figure 5), while His379 is close 
to the luminal side of the ER and Asp339 was 
cytosolic. 
Cytoplasmic cysteine accessibility suggests 
cysteine modification and a stabilising role for 
Cys324 - HHAT has 14 cysteines and, based on  
the consensus experimental topological model of 
HHAT described above (Figure 5), HHAT is 
predicted to have three luminal cysteines, C126-
C139-C282, and four cytosolic cysteines, C188-
C242-C324-C410, while the rest of the cysteines 
are embedded in the hydrophobic core of the 
membrane. 
In order to examine this prediction, we 
transfected cells with the wild type HHAT-V5-
6xHis construct and either fully permeabilised 
the cells with 1% Triton X-100 or semi-
permeabilised the cells with 0.04% digitonin, 
and treated the cells with mPEG (Figure 6A).  
The ER membrane was intact in digitonin-
treated cells, as GRP94 was not modified.  
Surprisingly, in fully permeabilised cells there 
was only a SDS-PAGE shift of HHAT-V5-
6xHis corresponding to ~15kDa (analysis on 4 
experiments indicate a shift of 14.1 +/- 0.84 
kDa) indicating that only 3 cysteines had been 
modified by mPEG (which has a molecular 
weight of ~5kDa).  Even more surprisingly, in 
the semi-permeabilised cells, no band shift was 
seen, indicating that all three tagged cysteines 
were luminal.  This supports our hypothesis that 
three cysteines of HHAT would be in the lumen 
of the ER, but raised a question as to why no 
cytosolic cysteines were accessible. 
It is possible that cytosolic cysteines are not 
accessible to mPEG through steric hindrance 
from the secondary, tertiary or quaternary 
structure of the cytosolic loops.  Another 
possibility is that the –SH groups of the 
cysteines are not available to react with mPEG 
because of another modification or formation of 
a disulphide bond with neighbouring cysteines, 
although this is unlikely for cytosolic cysteines 
due to the reducing environment of the 
cytoplasm. This was also excluded by running 
HHAT on non-reducing gels, in which we did 
not see altered mobility which would be 
evidence of disulphide bond formation (data not 
shown).  Thus, either the cysteines were 
inaccessible or they were modified in some other 
way. 
We performed an alanine scan of all cysteines 
followed by mPEG labelling in fully 
permeabilised cells in order to see if we could 
identify the cysteines that were being labelled 
with mPEG (Figure 6B).  None of the single 
cysteine mutations resulted in a quantifiable 
reduction of the mPEG modification of HHAT.  
Unusually, the cysteine mutant C324A when 
tagged with mPEG gave rise to multiple bands 
of increasing size (Figure 6B, lane 10 in right 
hand blot and 6C), suggesting that by mutating 
this single cysteine, other cysteines within the 
protein somehow become accessible and/or 
multimer formation is promoted. 
HHAT is palmitoylated on multiple cytoplasmic 
cysteines - The inaccessibility of HHAT 
cytosolic cysteines to the mPEG alkylating 
reagent and the lack of disulphide bonds in the 
protein suggested that the cysteines are perhaps 
modified in some other way.  We hypothesised 
that HHAT is palmitoylated, partly based on 
studies showing that the DHHC PATs form an 
auto-acylated intermediate (29) before acylating 
their substrate proteins.  Furthermore, cytosolic 
juxtamembrane cysteines of transmembrane 
proteins are frequently palmitoylated.  
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Therefore, we decided to examine if HHAT was 
acylated.   
HEK293a cells overexpressing human HHAT-
V5-6xHis were metabolically labeled with 
YnPalm (alkynyl-palmitate analogue pentadec-
14-ynoic acid) (17), cells were lysed and HHAT 
was immunoprecipitated via it’s C-terminal V5 
tag onto protein G beads.  Precipitated proteins 
were then subjected to CuAAC ligation to azide-
containing trifunctional capture reagent azido-
TAMRA-PEG-Biotin (AzTB) (17).  Proteins 
were separated by SDS-PAGE and 
palmitoylated proteins were then identified by 
in-gel fluorescence (upper panels) and verified 
by anti-6xHis immunoblotting (lower panels) 
(Figure 7A).  As is seen in the input samples 
(upper left panel) there are multiple bands, 
corresponding to all the proteins in the 
palmitoylome of the cell; however, after V5 
immunoprecipitation (upper right panel) a major 
band is visible at 50kDa corresponding to 
palmitoylated HHAT.  Furthermore, treatment of 
the lysates with hydroxylamine (NH2OH) at 
neutral pH, which cleaves thioester bonds, 
before V5 pull-down and CuAAC ligation, led to 
a loss in HHAT palmitoylation signal (Figure 
7B), confirming that HHAT is palmitoylated via 
a thioester bond on at least one cysteine residue.   
We used the cysteine-to-alanine mutants 
discussed above in similar metabolic labelling 
experiments and in Acyl-RAC pulldown 
experiments (30).  However, no single cysteine 
resulted in significant decreased pulldown, 
suggesting that multiple cysteines were being 
acylated (data not shown). 
Based on our experimentally determined 
topology of HHAT (Figure 5), four cysteines, 
C188-C242-C324-C410, are expected to be on 
the cytosolic side of the ER membrane, where 
palmitoylation by DHHC PATs is expected to 
occur.  We made two multiple cysteine-to-
alanine mutants, in which either all four 
cysteines were mutated to alanine (4CysA), or 
just three of the cysteines were mutated 
(3CysA), leaving out Cys188 which is predicted 
to be within a re-entrant loop and so may not be 
accessible to mPEG modification (see section 
above).  These mutants were metabolically 
labelled with YnPalm and analysed by anti-V5 
precipitation and CuAAC ligation to AzTB 
(Figure 7C).  In the HHAT-3CysA mutant, there 
was a decrease in palmitoylated HHAT signal, 
although a faint band was still visible in the in-
gel fluorescence (see Figure 7C; gel on the right, 
compare lane 4 with lane 8).  However, mutation 
of all four cysteines to alanine in the HHAT-
4CysA mutant, led to a complete loss of YnPalm 
signal (compare lane 4 with lane 10), indicating 
that all four cysteines on the cytosolic side of the 
protein are palmitoylated.  Significantly, a 
mutant protein in which all the predicted luminal 
cysteines were mutated to alanine, HHAT-
LumCys mutant, was still palmitoylated to an 
equal extent as the wild type protein (compare 
lane 4 with lane 6). 
Finally, we examined if HHAT activity was 
important for its palmitoylation.  The HHAT 
mutants D339N and H379A have significantly 
reduced activity (13), with D339N showing a 
severe loss of activity while H379A retained 
~60% activity of WT HHAT (Figure 8A).  
HEK293a cells overexpressing HHAT-D339N 
or HHAT-H379A were metabolically labelled 
with YnPalm and HHAT palmitoylation was 
examined by in-gel fluorescence (Figure 8B).  
These experiments showed that HHAT-D339N 
was still palmitoylated; however, HHAT-H379A 
was only weakly palmitoylated, indicating that 
the conserved His379 residue of the MBOAT 
region of HHAT is important for the 
palmitoylation of HHAT and that this may be 
critical for HHAT function.   
 
DISCUSSION 
In this study we have determined the topology of 
HHAT by TEV protease and V5 epitope 
mapping in microsome preparations and 
selectively permeabilised cells, respectively. 
While, we also have shown that HHAT is multi-
palmitoylated, which may affect protein 
function.  
The model we have developed (Figure 5) 
consists of 10 TMs and 2 RLs, with cytosolic N- 
and C-termini, and the conserved His379 residue 
from the MBOAT domain being at the lumenal 
tip of TM-9 and the critical Asp339 in a large 
cytosolic loop, which contains a palmitoyalted 
Cys.  This model is significantly different from 
the previously proposed model, which consisted 
of 8TMs, and the His and Asp residues were in a 
single large cytosolic loop (13).  Our 
experimentally validated model shows a good 
correlation with the predicted topologies of both 
TOPCONS and MEMSAT-SVM algorithms, the 
biggest discrepancy being that neither model 
predicted any RLs.  This is perhaps not 
surprising as, despite both TOPCONS and 
MEMSAT-SVM containing features to identify 
RLs, the accuracy of predicting such regions is 
significantly lower (22,31).  Furthermore, we do 
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not know to which class of RL they belong (31) 
nor indeed if the RLs actually enter the 
membrane at all or rather form some globular 
domain. 
To date, the topology of two other members of 
the MBOAT family of proteins that acylate 
proteins, Gup1p and GOAT, have been 
examined in any great detail.  Both had complex 
models that were, however, similar to the HHAT 
topology in our study.  Gup1p, a yeast protein 
that acylates (with C26:0) GPI-anchored 
proteins, was found to have 9TMs and 3 RLs 
(32), while GOAT recently was shown to 
contain 11TMs and 1RL (21).  In both cases, the 
invariable His residue was luminal and the 
conserved Asn was cytosolic, similar to what we 
observe for HHAT, further enhancing the theory 
that all MBOATs have this structure for their 
proposed active sites (21,32,33).  HHAT is 
unusual compared to the other MBOAT 
proteins, in that mutation of the invariable His 
residue of the MBOAT region does not 
completely abolish catalytic activity of the 
protein (Figure 8A) (13).  This suggests that 
HHAT may function in a different manner to 
other members of the family.  However, our 
model does not indicate, at least from a 
topological point of view, that the active site is 
different from that of Gup1p or GOAT.  
Alternatively, substrate specificity may underlie 
this difference; GOAT and Gup1 acylate serine 
and glycerol, respectively, both oxygen 
nucleophiles, whereas HHAT acylates a thiol.  
His may act as base to enhance the nucleophilic 
character of the Ser hydroxyl group via 
activation/deprotonation, but in the case of 
HHAT the Shh cysteine may be a sufficiently 
good nucleophile to attack Palm-CoA without 
activation.  However, similar to what has been 
shown for other MBOAT proteins, mutation of 
the conserved Asp in HHAT does abrogate 
function completely (Figure 8A) (13).  The 
cytosolic location of this residue suggests that it 
is not directly involved with the palmitoylation 
of Hh proteins, and likely is involved with either 
substrate recognition or HHAT stability.  
Although Asp 339 is cytosolic, it is in the same 
loop as the palmitoylated Cys 324 which would 
insert into the bilayer and have the effect of 
bringing this loop back up to the membrane 
surface where Asp339 could interaction with 
substrates. 
RLs can have multiple functions within proteins, 
especially in pore forming transport channels.  In 
Aquaporins, two RLs are surrounded by 6 TMs, 
thus lining the channel and providing selectivity 
to the transporter specifically for water 
molecules (34), while in the Glutamate transport 
proteins, a RL determines substrate binding 
within the pore (35).  RLs can also stabilise the 
subunits of different channels through 
electrostatic interactions (36).  It will be 
important to examine whether RL6 in both 
GOAT and HHAT functions in substrate 
recognition, especially as the acyl-CoA is 
negatively charged and it may be possible that 
RLs can create regions of positive electrostatic 
potential to aid the interaction (36).  These 
regions may also affect the formation of HHAT 
multimers; although GOAT is suggested to exist 
and function as a monomer (21), HHAT does 
form non-covalent dimers in cells (see Figure 
6B) as well as when the protein is purified in 
vitro (data not shown).  It is unclear if the 
protein functions as a monomer or as a dimer; 
however, recent studies in the DHHC PATs 
revealed that DHHC2 and DHHC3 form inactive 
dimers,  and dimerisation is inhibited by the 
autoacylation (37). 
Using metabolic labelling experiments and 
multiple Cys to Ala mutants of HHAT we 
further show that HHAT is S-palmitoylated on 
four cytosolic Cys residues. Surprisingly, the 
impaired activity mutant HHAT H379A is only 
weakly palmitoylated indicating that 
palmitoylation of HHAT is important for its 
function.  This could imply that the role of 
His379 in HHAT would be that of a structural 
regulator in the protein rather than being 
involved in catalytic activity.  Unlike the DHHC 
PATs, where the importance of the DHHC motif 
and particularly of the Cys residue of the motif 
to the acylation of their target proteins is better 
understood, very little is known about how the 
invariant His residue of the MBOAT proteins 
functions in catalysis of the acylation of lipids 
and proteins.  In the DHHC PATs, autoacylation 
at the Cys residue of the motif occurs upon 
interaction with the acyl-CoA to form a transient 
acyl-enzyme transfer intermediate, before 
transferring the acyl group to the protein 
substrate (29).  It is likely that HHAT’s 
palmitoylation is not directly involved in the N-
palmitoylation of Hh proteins in a comparable 
manner to DHHC proteins, because HHAT 
acylation sites and Hh acylation occur on 
opposite sides of the membrane.  However, the 
palmitoylation of HHAT may modulate protein 
function and/or structure in other ways that 
ultimately may affect Hh protein palmitoylation. 
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A recent study showed that the closely related 
MBOAT protein PORCN, which attaches a 
palmitoleoyl moiety to the Wnt family of 
proteins, is also palmitoylated (38).  This study 
suggested that PORCN was palmitoylated on a 
single Cys, conserved only in primates, 
specifically Cys187 of human PORCN, and that 
palmitoylation of PORCN resulted in a reduction 
of palmitoleoylation and activity of Wnt proteins 
(38).  However, it is likely that multiple PORCN 
Cys residues are palmitoylated similar to the 
situation with HHAT, as mutation of Cys187 to 
an Ala did not completely abrogate PORCN 
palmitoylation (38).  Furthermore, it is unclear 
how a primate-specific Cys in PORCN would 
modulate Wnt activity so radically, especially as 
the function of PORCN is completely conserved 
in mice, which don’t have this Cys residue.  
Unlike PORCN, all Cys residues palmitoylated 
in HHAT are conserved in primates and other 
mammalian sequences, such as mice and rat 
(Figure S1).  Significantly, mutation of the His 
residue of PORCN did not affect palmitoylation 
of the protein, suggesting that this is a unique 
feature for HHAT.  This result, when taken in 
consideration with the data that show that 
HHAT is the only known MBOAT in which 
mutation of the His residue still retains some 
activity of the protein, may suggest that HHAT 
does function in an unique manner compared to 
other MBOAT proteins. 
Unlike the N-palmitoylation of Hh proteins, S-
palmitoylation is catalysed by the DHHC PATs 
and attaches palmitic acid to proteins via 
thioester linkages to cysteine residues.  This is a 
reversible process, via the function of the acyl-
protein thioesterases (APTs), and as such it can 
be considered an “on-off” switch similar to 
protein phosphorylation (39).  Palmitoylation of 
membrane proteins has been shown to affect 
association with other proteins (40), or the 
targeting of ER membrane proteins to specific 
domains within the ER membrane (41).  HHAT 
palmitoylation could potentially have a similar 
effect on the protein.  Future studies, perhaps 
with mass spectrometry analysis of HHAT-
associated proteins or super-resolution 
microscopy of HHAT mutants, should provide 
clues to both possibilities.  Insertion of the 
palmitates into the cytoplasmic leaflet of the ER 
may also locally affect membrane curvature to 
aid in interaction with the acyl-CoA or Hh 
substrates. 
Another potential function is that palmitoylation 
affects the structure of HHAT.  Palmitoylation 
of model proteins with a single TM in residues 
adjacent to the TM, disrupts the orientation of 
the helices within a lipid bilayer (42). 
Palmitoylation of HHAT may effect the tilting 
of the TMs within the ER membrane, thus 
affecting protein function.  Repeating the 
experiments presented in this study with 
palmitoylation-deficient mutants of HHAT and 
seeing if topology is altered could test this 
hypothesis.   
The result that the H379A mutant is not 
palmitoylated would perhaps suggest that the 
protein is actually autoacylated. However, due to 
the fact that the D339N HHAT mutant is only 
weakly active and yet still fully palmitoylated, it 
is likely that HHAT palmitoylation is not caused 
by autoacylation of the protein. Thus, 
identification of the DHHC PAT responsible for 
HHAT palmitoylation, as well as the interplay 
with the APTs, may provide a further dimension 
of how this protein is regulated by 
palmitoylation. 
Finally, during mPEG accessibility analysis on 
the HHAT Cys mutants, an unexpected result 
was seen with the C324A mutant, the mPEG 
labelling produced significantly more bands, 
with a laddering effect of differentially tagged 
HHAT proteins (Figure 6C).  The increase in 
molecular weight could be attributed to 
increased multimerisation of the protein. It is 
still unclear if MBOAT family proteins form 
functional multimers within the cell, although 
studies on GOAT suggest that the protein 
functions as a monomer (21).  Intriguingly, this 
result could further suggest that the protein 
conformation is significantly altered in this 
protein, as more Cys residues within the protein 
are more accessible. The importance of this Cys 
residue is emphasised by the facts that it is the 
only Cys residue completely conserved in all 
examined species (Figure S1), and that it is also 
palmitoylated (Figure 7).  Further studies with 
this mutant should reveal more as to its 
importance in regulating HHAT function. 
In summary, we provide a comprehensive 
analysis of HHAT topology, showing that the 
protein consists of 10 TMs and 2 RLs, with the 
His residue of the proposed catalytic site facing 
the lumen of the ER.  We provide evidence that 
HHAT is palmitoylated on multiple Cys residues 
on the cytoplasmic side of the protein and that 
mutation of the invariant His residue of the 
MBOAT domain affects palmitoylation of 
HHAT, while also showing that Cys324 of the 
protein may be important for controlling its 
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folding.  From this study, it is clear that HHAT 
is an extremely complex protein with multiple 
factors affecting its function.  This study 
provides the foundation upon which to build an 
understanding to how HHAT functions and how 
it may be inhibited, as well as creating new 
avenues of inquiry for future studies in this 
important class of proteins. 
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FOOTNOTES 
Abbreviations: Hh, Hedgehog; HHAT, Hedgehog acyltransferase; PAT, protein acyltransferase; APT, 
acyl protein thioesterase; siRNA, small interfering RNA; TM, transmembrane domain; RL, re-entrant 
loop; ER, endoplasmic reticulum; MBOAT, membrane bound O-acyltransferase; PORCN, Porcupine; 
GOAT, Ghrelin-O-acyltransferase. 
 
FIGURE 1.  Bioinformatic prediction analysis of HHAT sequences identifies a maximum of 13 
predicted transmembrane domains (TMs).  Clustal Omega sequence alignment of human HHAT 
sequence with the TMs predictions from three separate bioinformatic algorithms: TOPCONS, 
MEMSAT-SVM and TMpred.  Predicted TMs are highlighted in red and loops are numbered in 
accordance with the epitope insertion analysis from our experiments.  The TMpred algorithm 
predicted a helix within loop 8, and so mutants were made at two places in the loop between predicted 
TMs 8 and 9, in order to accommodate this prediction.  These mutants were numbered 8 and 8b.  In 
all models, the critical His379 residue is predicted to be part of TM-9.  Positions selected for epitope 
and TEV tag insertions used in this study are indicated with arrows.  The diagrams below depict the 
predicted topologies from each of the algorithms, along with the predicted loop location.  The black 
boxes depict the predicted TMs, while the lines depict the loop regions.  Loops are coloured red and 
blue depending on if they were predicted to be luminal or cytosolic, respectively.  In the MEMSAT-
SVM diagram TMs 5, 6 and 8 were predicted to be pore-lining helices, which are depicted in 
magenta.  Loops and TMs are not drawn exactly to scale, but do indicate relative size differences. 
 
FIGURE 2.  Mapping of HHAT topology by TEV cleavage of microsomal preparations. HHAT 
constructs containing a C-terminal V5-6xHis epitope tag and an internal TEV protease tag at indicated 
loops were transfected into HEK293a cells and intact microsomal preparations prepared by 
ultracentrifugation. A. In order to show that the microsomal preparations have intact ER membranes, 
mPEG, a hydrophilic reagent of 5 kDa that reacts with -SH groups, did not react with the non-
disulphide-bonded cysteine in the ER luminal protein GRP94 when it was added to 10g of the 
microsomal preparations (A. I.).  After treatment of the microsomes with 0.2% Triton-X 100 (A. II.) 
GRP94 is modified by mPEG, and the reaction could be blocked by the reducing agent DTT (A. III.).  
GRP94* indicates the position of the modified proteins.  B. Microsome preparations were treated with 
TEV-Buffer (I) or Pro-TEV protease (see Experimental procedures) (II) for 4h at 25
o
C with agitation.  
Reaction was then stopped with sample buffer and samples analysed by SDS-PAGE and probed 
firstly with anti-V5 antibody, and then reprobed with anti-6xHis antibody.  Because the microsomal 
preparations are intact, any TEV cleavage sites on luminal loops will be inaccessible to the Pro-TEV 
protease.  However, any cytosolic sites will be accessible to the protease and so the protein will be 
cleaved and produce a shorter C-terminal fragment, which will be identified by antibody labelling.  
Using this method the HHAT topology model indicated below figure (C. II.) was produced; red lines 
indicate the TEV site was inaccessible and hence luminal, blue lines indicate the TEV site was 
accessible and hence cytoplasmic.  Cleaved bands are indicated by black arrowheads, while grey 
arrowheads indicate potential cleaved products.  It was unclear if mutants 1/2 and 2/3 produced any 
cleavage product.  Immunoblots shown are representative results from 5 independent experiments.  D. 
A construct containing the TEV protease tag in the linker sequence between the C-terminal V5 
epitope and the 6xHis epitope tag was used to examine the topology of the C-terminus of HHAT.  
Specifically, if the C-terminus is cytosolic and accessible to TEV protease cleavage, reactivity of the 
protein with a 6xHis antibody would be lost after treatment with Pro-TEV, while reactivity with the 
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V5 antibody should be retained.  This is what was observed in the experiments with this construct, 
indicating that the C-terminus is cytosolic.   
 
FIGURE 3.  Mapping of HHAT topology by V5 epitope indirect immunofluorescence in selectively 
permeabilised cells.  HHAT constructs containing a C-terminal FLAG epitope tag and an internal V5 
epitope tag at indicated loops were transfected into HeLa cells plated on 96-well imaging plates.  Cell 
membranes were either permeabilised with 0.2% Triton-X 100 (TX100) or with 0.04% digitonin 
(Dig).  Permeabilisation with digitonin maintains the ER membrane intact, while permeabilisation 
with Triton-X 100 fully permeabilises all the membranes of the cell.  FLAG and V5 epitopes were 
stained with specific primary antibodies, followed by secondary antibodies with 555nm (red) or 488 
(green) excitation wavelengths, respectively. To control for the selective permeabilisation of the ER 
membrane, untransfected cells were selectively permeabilised and stained for Calnexin using two 
different antibodies, one which binds to an epitope on the luminal N-terminus of the protein and 
another which bind to an epitope on the cytosolic C-terminus of the protein (I).  Only two conditions 
are shown, for the V5 epitope in the N-terminus of the protein (II) and in predicted loop 1 (III).  The 
N- and C-termini of HHAT were both cytosolic (II), thus the FLAG epitope will always be stained, 
regardless of detergent used for permeabilisation.  Images were then analysed using Volocity image 
analysis software to determine the colocalisation coefficient of the two channels.  Insets show higher 
magnification of indicated regions. The histogram (IV) shows mean Manders’ coefficients (MC) for 
colocalisation of the red (555nm) channel with the green (488nm) channel for different HHAT 
mutants and for the Calnexin control (n>40 cells, error bars indicate the standard deviation).  High 
Manders’ coefficients indicate better colocalisation of FLAG-tagged proteins with V5-tagged 
proteins.  Values less than 0.5 indicate low colocalisation. Identical exposures and image 
normalisation for both permeabilisations ensure fair side-by-side comparison.  Schematics underneath 
panels II and III illustrate the positions of the stained epitopes. Images are examples of each condition 
from at least three independent experiments.  Scale bars: 15m. 
 
FIGURE 4.  N-glycosylation analysis of full length HHAT, HHAT-157-493 and HHAT-192-493 
truncation mutants, containing a C-terminal N-glycosylation motif.  In vitro translation/translocation 
of HHAT truncations ending in predicted loop regions 4 (157-493 mutant) and 5 (192-493 mutant), 
or full length HHAT cDNA, C-terminally tagged with an N-glycosylation site and a V5 epitope.  
Luminal N-glycosylation sites become glycosylated and the covalent attachment to the protein can be 
detected by a shift in molecular weight on an SDS-PAGE gel.  Following expression, lysates were 
treated or not with PNGase F, an endoglycosidase which cleaves N-glycans between the innermost 
sugar moiety and Asn, removing the shift in molecular weight of glycosylated proteins.  Lysates were 
analysed by SDS-PAGE on 7.5% gels, followed by immunoblotting with anti-V5 antibody.  HHAT* 
indicates glycosylated HHAT protein. 
 
FIGURE 5.  HHAT topology experimental consensus model indicates 10 TMs and 2 re-entrant loops 
(RLs).  Figure displays the consensus HHAT topology model including palmitoylation modifications, 
based on the data shown in the table below which summarises the results from the three different 
experiments, indicating if a loop is luminal (L) or cytoplasmic (C), the consensus model is indicated 
at the bottom.  Our data indicate that predicted TM-3 and TM-6 are likely to be RLs.  The cytosolic 
loops containing cysteines that are palmitoylated display the fatty acid modification as a bent line.  
Relative loop length is approximated by the size of the loops, but not precisely scaled; cytosolic loops 
are coloured blue and luminal loops red.  Positions of the two conserved MBOAT residues, Asp339 
and His379, are indicated with arrows. 
 
FIGURE 6.  HHAT cysteine mapping in selectively permeabilised cells.  A. HEK293a cells 
expressing HHAT-V5-6xHis were permeabilised with 0.04% digitonin or 1% Triton X-100 as 
indicated.  Modification was carried out for 30 min at 4°C with 1 mM mPEG.  Samples were analysed 
by SDS-PAGE on 7.5% gels, followed by immunoblotting with antibodies to V5 (upper panel) or 
GRP94 (lower panel).  B. HEK293a cells expressing the indicated HHAT single cysteine mutants 
were permeabilised with 1% Triton X-100.  Modification was carried out for 30 min at 4°C with 1 
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mM mPEG; where indicated, DTT was present during the reaction.  Samples were analysed by SDS-
PAGE on 7.5% gels, followed by immunoblotting with antibodies to V5 (upper panels) or GRP94 
(lower panels).  Immunoblots shown are representative results from 4 independent experiments.  C. 
HEK293a cells expressing HHAT C324A mutant were permeabilised with 1% Triton X-100.  
Modification was carried out for 30 min at 4°C with 1 mM mPEG; where indicated, DTT was present 
during the reaction.  Samples were analysed by SDS-PAGE on 7.5% gels, followed by 
immunoblotting with antibodies to V5 (upper panel) or GRP94 (lower panel).  HHAT* and GRP94* 
indicate the positions of the modified proteins. 
 
FIGURE 7.  HHAT is palmitoylated on multiple cysteines via thioester linkage.  A. HEK293a cells 
were transfected with a construct expressing the WT human HHAT cDNA C-terminally tagged with 
V5 and 6xHis epitopes.  Cells were then fed overnight with 50M palmitic acid analogue with a 
clickable alkyne moiety (YnPalm) or with vehicle (0.1% DMSO).  Cells were lysed and HHAT was 
immunoprecipitated (IP) using anti-V5 antibody.  Immunoprecipitated proteins or lysates were ligated 
by CuAAC to AzTB.  Tagged proteins were separated on 15% SDS-PAGE gels and analysed by in-
gel fluorescence (upper panels) and immunoblotting with antibody against 6xHis (lower panels).  B. 
Lysates were prepared as in previous experiment; however, before immunoprecipitation lysates were 
either treated with 1M NH2OH pH 7.5 or 1M Tris pH 7.5 for 5h at room temperature, as described in 
the materials and methods section.  Lysates were then precipitated by chloroform/methanol 
precipitation, resolubilised in 0.2% Triton X100 in PBS, immunoprecipitated with V5 antibody, 
ligated by CuAAC to AzTB and analysed by SDS-PAGE in-gel fluorescence (upper panel) and anti-
6xHis immunoblotting (lower panel).  C. HEK293a cells were transfected with constructs expressing 
WT human HHAT cDNA, the luminal cysteine mutant HHAT-LumCys, or the cytosolic cysteine 
mutants HHAT-3CysA or HHAT-4CysA.  Cells were then fed overnight with 50M YnPalm or 0.1% 
DMSO.  Cells were then lysed, immunoprecipitated with anti-V5 antibody, ligated by CuAAC to 
AzTB and analysed by SDS-PAGE in-gel fluorescence (upper panels) and anti-6xHis immunoblotting 
(lower panels). 
 
FIGURE 8.  His379 is implicated in HHAT palmitoylation.  A. HHAT activity for the D339N and 
H379A mutants was determined by measuring the ability of the purified and solubilised HHAT 
mutant proteins to palmitoylate a Shh peptide, using an in-house developed in vitro click-chemistry 
based palmitoylation assay. HHAT-D339N-V5-6xHis showed only ~3% activity compared to WT, 
while HHAT-H379A-V5-6xHis mutant had ~63% activity compared to WT.  Data are presented as 
mean ± SD and normalised to HHAT-WT-V5-6xHis.  B. HEK293a cells were transiently transfected 
with HHAT-D339N-V5-6xHis or HHAT-H379A-V5-6xHis mutant constructs.  Cells were then fed 
overnight with 50M YnPalm or with 0.1% DMSO.  Cells were lysed and HHAT was 
immunoprecipitated using a V5 antibody.  Immunoprecipitated proteins or lysates were ligated by 
CuAAC to AzTB.  Tagged proteins were separated on 15% SDS-PAGE gels and analysed by in-gel 
fluorescence (upper panel) and immunoblotting with antibody against the His tag (lower panel).  Gels 
and immunoblots shown are representative results from 2 independent experiments. 
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